Top Stories By Asset Article Promo
Syngenta sows seeds of giant HK IPO

Seeds and crop protection giant Syngenta Group met banks last week to pick IPO arrangers for what could be the largest listing in Hong Kong in seven years.

EQY
Software 'shitstorm' grounds Liftoff listing

Liftoff Mobile pulled its up to US$762m Nasdaq IPO on Thursday evening in the wake of the week's selloff of software stocks due to investor concerns about the threat to the sector from AI.

EQY
Top Stories By Asset Article Promo
Oracle takes bottom-up approach to funding 2026 capex

Amid an unprecedented AI-focused borrowing binge, Oracle became the first of the hyperscalers to blink on the public equity side, raising US$5bn from the sale of a mandatory convertible preferred, while filing to sell another US$20bn of stock on the open market through an at-the-market programme.

EQY
Top Stories By Asset Article Promo
Asia equity-linked makes rapid start

Asia's equity-linked issuance has got off to a rapid start this year, with 15 deals raising US$9.9bn on strong investor appetite for the product.

EQY
Top Stories By Asset Article Promo
Forgent powers through jumbo IPO as AI fuels demand

Forgent Power Solutions raised US$1.5bn on Wednesday from a NYSE IPO that was heavily oversubscribed, though the lead banks were reluctant to push too hard on pricing.

EQY

Latest Equities Stories By Region and Type

Americas
Europe, Middle East and Africa
Asia / Pacific
Initial Public Offerings (IPO)
Structured Equity
Americas
  • Americas
  • Europe, Middle East and Africa
  • Asia / Pacific
  • Initial Public Offerings (IPO)
  • Structured Equity

IFR US ECM Calendar

Forgent powers through jumbo IPO as AI fuels demand

Updated:

Software sell-off puts US IPO market on tilt

Once Upon a Farm harvests US$198m on NYSE IPO

Updated:

VSE upsizes share, mandatory convertible combo

Nlight fell below issue after US$175m raise

BlackRock anchors Clear Street's US$1.05bn IPO

Updated:

IFR US ECM Weekly Review

Oracle takes bottom-up approach to funding 2026 capex

Updated:

Big Pharma backs biotech IPOs with strategic investments

Updated: